Life after Lantern: All Mental Health wants to make evidence-based mental health resources accessible by all

The data-driven transformation of the life sciences industry: A Q&A with ZS Associates’ Pete Masloski

Digital health innovation continues moving full-force in transforming the business of healthcare. For pharma and medtech companies in particular, this ongoing shift has pushed them to identify ways to create value for patients beyond the drugs themselves. From new partnerships between digital health and life science companies to revamped commercial models, collecting and extracting insights from data is at the core of these growth opportunities. But navigating the rapidly evolving terrain is no simple task. We chatted with ZS Associates Principal Pete Masloski to discuss how he works with clients to help identify, develop, and commercialize digital health solutions—and where he sees patients benefiting as a result.